Advertisement Gerresheimer Signs Agreement for €325m Promissory Loan - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
More info about Gerresheimer

Gerresheimer Signs Agreement for €325m Promissory Loan

Gerresheimer AG has signed a promissory loan agreement for a total of €325m. The transaction with an initial issue amount of €150m was substantially oversubscribed. Consequently, the total amount was increased to €325m.

The promissory loan comprises two equal tranches with terms of three and five years. These feature both fixed and variable interest rates. The transaction is coordinated by Commerzbank, Landesbank Baden-Württemberg and UniCredit. For the most part, the funds from the loan are being used to repay the five-year tranche under the 2015 promissory loan transaction.

“The high oversubscription ratio reflects the confidence held by our investors in our business model and the successful long-term performance of our business,” said Dr. Bernd Metzner, CFO of Gerresheimer AG. “We are pleased to be able to complete the refinancing of the maturing promissory loan on even more attractive terms.” Completion is scheduled for November 10, 2020.